{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:11:30Z","timestamp":1782447090795,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"NSF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ijpharm.2016.07.018","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T23:44:20Z","timestamp":1468367060000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Solid-state characterization of optically pure (+)Dihydromyricetin extracted from Ampelopsis grossedentata leaves"],"prefix":"10.1016","volume":"511","author":[{"given":"Chenguang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathyanarayana","family":"Reddy Perumalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-5334","authenticated-orcid":false,"given":"Changquan","family":"Calvin Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijpharm.2016.07.018_bib0005","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrd915","article-title":"Putting chirality to work: the strategy of chiral switches","volume":"1","author":"Agranat","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ijpharm.2016.07.018_bib0010","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1073\/pnas.71.10.4246","article-title":"Stereospecific binding of propranolol and catecholamines to the \u03b2-adrenergic receptor","volume":"71","author":"Atlas","year":"1974","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"8231","key":"10.1016\/j.ijpharm.2016.07.018_bib0015","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(81)92372-2","article-title":"Myasthenia-like syndrome after D, L-but not L-carnitine","volume":"317","author":"Bazzato","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0020","series-title":"APEX, SADABS and SAINT","author":"Bruker","year":"2007"},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.018_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.chroma.2005.04.024","article-title":"High-performance liquid chromatographic separation and chiroptical properties of the enantiomers of naringenin and other flavanones","volume":"1076","author":"Caccamese","year":"2005","journal-title":"J. Chromatogr. A"},{"issue":"3","key":"10.1016\/j.ijpharm.2016.07.018_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1359-6446(03)02904-0","article-title":"Trends in the development of chiral drugs","volume":"9","author":"Caner","year":"2004","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.ijpharm.2016.07.018_bib0035","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2125.1986.tb02966.x","article-title":"Enantiomers of warfarin and vitamin K1 metabolism","volume":"22","author":"Choonara","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.018_bib0040","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/chir.530010103","article-title":"The FDA perspective on the development of stereoisomers","volume":"1","author":"De Camp","year":"1989","journal-title":"Chirality"},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0045","unstructured":"Fang, J., Wang, W., Shi, C., et al., Five solid form of dihydromyricetin, CN201410715828.5."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.018_bib0050","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.15376\/biores.11.1.2712-2722","article-title":"Development of improved process with treatment of cellulase for isolation of ampelopsin from dried fruits of ampelopsis grossedentata","volume":"11","author":"Gao","year":"2016","journal-title":"BioResources"},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.018_bib0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/AAC.29.1.163","article-title":"Synthesis and antibacterial activities of optically active ofloxacin","volume":"29","author":"Hayakawa","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2015.03.007","article-title":"Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways","volume":"130","author":"Hou","year":"2015","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.018_bib0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.fshw.2012.08.001","article-title":"Pharmacological potential of ampelopsin in Rattan tea","volume":"1","author":"Kou","year":"2012","journal-title":"Food Sci. Hum. Welln."},{"issue":"10","key":"10.1016\/j.ijpharm.2016.07.018_bib0070","doi-asserted-by":"crossref","DOI":"10.1107\/S1600536810037578","article-title":"Dihydromyricetin hexaacetate","volume":"66","author":"Li","year":"2010","journal-title":"Acta Crystallogr. Sec. E Struct. Rep. Online"},{"issue":"2","key":"10.1016\/j.ijpharm.2016.07.018_bib0075","first-page":"17","article-title":"Stability of dihydromyricetin and factors affecting the stability","volume":"23","author":"Lin","year":"2004","journal-title":"J. Wuxi Univ. Light Ind."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.07.018_bib0080","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/jps.21033","article-title":"Characterization of the hygroscopic properties of active pharmaceutical ingredients","volume":"97","author":"Newman","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0085","series-title":"Novel Optical Resolution Technologies","author":"Sakai","year":"2007"},{"issue":"1","key":"10.1016\/j.ijpharm.2016.07.018_bib0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. Sec. A Found. Crystallogr."},{"issue":"7","key":"10.1016\/j.ijpharm.2016.07.018_bib0095","first-page":"3114","article-title":"Pharmacokinetics of the diastereoisomers of leucovorin after intravenous and oral administration to normal subjects","volume":"44","author":"Straw","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jpba.2015.06.030","article-title":"Determination of dihydromyricetin in rat plasma by LC\u2fffMS\/MS and its application to a pharmacokinetic study","volume":"114","author":"Tong","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0105","unstructured":"Wang, W., Xiong, W., Fang, J., et al., Control the racemaction rate of dihydromyricetin, CN201510062355.8."},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0110","doi-asserted-by":"crossref","DOI":"10.1021\/acs.cgd.6b00591","article-title":"Enhancing bioavailability of dihydromyricetin through inhibiting precipitation during dissolution of soluble cocrystals by a crystallization inhibitor","author":"Wang","year":"2016","journal-title":"Cryst. Growth Des."},{"issue":"11","key":"10.1016\/j.ijpharm.2016.07.018_bib0115","doi-asserted-by":"crossref","DOI":"10.1107\/S1600536807050416","article-title":"Racemic dihydromyricetin dihydrate","volume":"63","author":"Xu","year":"2007","journal-title":"Acta Crystallogr. Sec. E Struct. Rep. Online"},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/9781118468524.ch3","article-title":"Chiral methods of flavonoid analysis","author":"Y\u00e1\u00f1ez","year":"2012","journal-title":"Flavonoid Pharmacokinet. Methods Anal. Preclin. Clin. Pharmacokinet. Saf. Toxicol."},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0125","first-page":"9","article-title":"Regulatory and development considerations of chiral compounds","author":"Zeid","year":"2011","journal-title":"Chiral Sep. Methods Pharm. Biotechnol. Prod."},{"key":"10.1016\/j.ijpharm.2016.07.018_bib0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.05.009","article-title":"Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial","volume":"99","author":"Zhao","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.07.018_bib0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12034-010-0042-8","article-title":"Preliminary investigations of antioxidation of dihydromyricetin in polymers","volume":"33","author":"Zheng","year":"2010","journal-title":"Bull. Mater. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316306482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T22:21:54Z","timestamp":1712442114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316306482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0378517316306482"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.018","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solid-state characterization of optically pure (+)Dihydromyricetin extracted from Ampelopsis grossedentata leaves","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}